Anders Åberg has join SPRINT BIOSCIENCE at the year of 2009. He completed his Phd in Molecular Biology from Stockholm University.He has experiesnce on CSO Sidec AB (2005–2008), Head of department AstraZeneca, Mölndal (2001–2005), Member of the board Kancera (2009–2010).He is holding shares of 347 684
Molecular Biology